Trexquant Investment LP - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$169,000
-64.1%
17,455
-33.7%
0.01%
-73.0%
Q3 2021$471,000
+40.2%
26,321
+91.4%
0.04%
+32.1%
Q2 2021$336,000
+232.7%
13,749
+3.2%
0.03%
+154.5%
Q4 2020$101,000
-44.5%
13,323
-63.4%
0.01%
-8.3%
Q3 2020$182,000
+2.8%
36,363
+22.7%
0.01%0.0%
Q2 2020$177,000
-33.0%
29,642
+6.9%
0.01%
-25.0%
Q4 2019$264,00027,7390.02%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders